OPTIMIZE-UC: Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis
Study Details
Study Description
Brief Summary
This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients starting new medical UC treatment. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Rationale: Despite considerable advances in the knowledge of UC, and a variation of treatment options, UC still impacts patients' ability to lead a normal life. Clearly, there is an unmet need to improve treatment outcomes. Prehabilitation programs in surgery have shown that the amount of complications is closely related to preoperative physical fitness, nutritional status and psychological well-being. IBD patients often search for self-management strategies to manage their symptoms, however, research focussing on a multimodal intervention approach in parallel to starting new IBD treatment is lacking. Given the potential benefits of intervention programs, limitations of current treatments in terms of improving quality of life and patients' desire for self-management options, we believe that exploring the results of a multimodal intervention program in patients starting new IBD treatment is of high relevance.
Objective/study design: This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in UC patients starting new medical UC treatment. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Study population: Patients ≥ 18 years old, with moderately to severely active UC, not responding to their existing treatment for UC therefore necessitating change of treatment.
Intervention: In parallel to starting new IBD treatment patients will undergo a multimodal intervention program in parallel to starting new IBD treatment including an exercise program, nutritional intervention and psychological evaluation.
Main study parameters/endpoints: This study assesses the feasibility and optimal timing of a multimodal intervention program. Secondary, assesses the effect on:
-
Individual patients' level, i.e. physical fitness, nutritional status, mental health, quality of life and work productivity and activity impairment.
-
Therapy outcomes, e.g. adherence, number and severity of (S)AEs, corticosteroid use, biochemical and clinical response/remission rates and patient reported outcomes.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Intervention group Patiënts will participate in multimodal intervention program in parallel to starting new UC medication |
Behavioral: Multimodal intervention program
Exercise intervention: combined endurance and resistance training three times a week using workout video's which patients can do at home. Advice to exercise at low-intensity for at least 30 minutes per day.
Nutritional intervention: Patients are advised to aim for optimal energy and protein intake (by registered dietician) and to avoid red meat, processed foods and sweetened drinks. Aiming for a mainly plant based diet.
Psychological intervention: screening for psychological risk factors and if present, patients are referred to a general practitioner or psychologist for psychological support.
|
| No Intervention: Control group Patiënts will receive standard care after starting new UC medication and are offered to partake in de intervention program at week 24 of the study. |
Outcome Measures
Primary Outcome Measures
- Accrural [24 weeks]
The percentage of approached, eligible participants that are included in the study.
- Attrition [24 weeks]
The percentage of participants who stopped the program prematurely.
- Adherence to exercise program [24 weeks]
Frequency of followed trainings
- Adherence to daily exercise goals [24 weeks]
SQUASH questionnaire
- Satisfaction [24 weeks]
Patient satisfaction will be assessed using a feasibility questionnaire
- Safety [24 weeks]
the number of adverse events occurring during the program
Secondary Outcome Measures
- Change in Oxygen Consumption (VO2 max) [1 year]
Indication of physical fitness
- Change in 1 repitition measures [1 year]
Indication of muscle strength
- Change in body weight [1 year]
Measured in kilograms
- Change in fat-free mass [1 year]
Measured with bioelectrical impedance analysis (BIA)
- Change in nutritional status [1 year]
Measured with Patient Generated Subjective Global Assessment (PG-SGA)
- Change in mental health [1 year]
Hospital Anxiety and Depression scale (HADS questionnaire)
- Change in Work Productivity and Activity Impairment [1 year]
Work Productivity and Activity Impairment Questionnaire (including WPAI-GH)
- Change in 36-Item Short Form Health Survey (SF-36) score [1 year]
Quality of life
- Change in EuroQoL (EQ-5D-5L) score [1 year]
Quality of life
- Change in Inflammatory Bowel Disease Questionnaire score [1 year]
Disease-related quality of life
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age ≥ 18 years old;
-
Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria;
-
Moderately to severely active UC defined by a Simple Clinical Colitis Activity Index (SCCAI) > 2 and biochemical parameters (C-reactive protein > 5 and/or fecal calprotectin > 200) or physician judgement, currently non-responsive to their existing treatment and requiring a change of treatment;
-
Ability of subject to participate fully in all aspects of this project;
-
Written informed consent must be obtained and documented.
Exclusion Criteria:
-
Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis;
-
Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder);
-
History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
-
History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
-
If female, the subject is pregnant or lactating or intending to become pregnant;
-
Immobilized patients who are not able to complete exercise intervention;
-
Illiteracy (disability to read and understand Dutch).
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Dorien Oomkens | Nijmegen | Netherlands | 6525GA |
Sponsors and Collaborators
- Radboud University Medical Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 114110